Warba Insurance and Reinsurance Company Stock Analysis 2026: Is WINSRE Worth Watching?
 |
| Warba Insurance and Reinsurance Company |
Worldreview1989 - Warba Insurance and Reinsurance Company (K.S.C.P.), traded on the Kuwait Stock Exchange under the ticker WINSRE, is a relatively small Gulf insurance company that may attract value and income investors looking beyond the large U.S. insurance market.
For American investors accustomed to companies such as Chubb, Progressive, Travelers, or Allstate, Warba offers a very different proposition: a small-cap Kuwaiti insurer with a combination of insurance operations, investment income, relatively high shareholder distributions, and a stock valuation that is substantially smaller than most U.S.-listed insurance companies.
The important question is not simply whether Warba is profitable. It is whether its profitability, capital position, underwriting performance, investment portfolio, dividend policy, and valuation provide enough margin of safety to compensate investors for the additional risks associated with a small foreign-market insurance stock.
Based on the latest available 2026 financial information, WINSRE presents an interesting value-and-income profile, but it remains a niche investment rather than a straightforward substitute for a large U.S. insurance company.
Investment view: WINSRE appears more suitable for investors seeking international insurance exposure, dividends, and potentially undervalued book value than for investors looking for rapid earnings growth.
1. Warba Insurance Stock: Company Overview
Warba Insurance and Reinsurance Company was established in Kuwait in 1976 and operates as a public Kuwaiti shareholding company.
The company's activities include:
General insurance
Motor insurance
Marine and aviation insurance
Fire and property insurance
General accident insurance
Life insurance
Medical insurance
Reinsurance
Investment activities
Warba reports its business through three principal operating segments:
General Risk Insurance
Life and Medical Insurance
Investment
The company's shares trade on the Kuwait Stock Exchange, with ticker WINSRE. Boursa Kuwait identifies Warba as listed company number 304.
For U.S. investors, this immediately creates an important distinction: WINSRE is not a conventional U.S.-listed insurance stock. Investors must consider Kuwait market access, currency exposure, liquidity, international brokerage availability, and foreign-market settlement procedures.
2. What Are American Investors Likely to Look For?
There is limited independent U.S. investor coverage of WINSRE, and the company's investor discussion footprint is much smaller than major American insurers.
Therefore, rather than claiming that a large population of American readers has reviewed Warba, the more useful approach is to evaluate the company through the questions commonly important to U.S. value and income investors.
Those questions include:
Is the company profitable?
Is earnings growth sustainable?
Is the balance sheet strong?
Is the stock cheap relative to book value?
Is the dividend sustainable?
How strong is underwriting?
How much profit comes from investments?
What happens if investment returns decline?
Is the company adequately capitalized?
Is the stock liquid enough for international investors?
These questions are particularly important because insurance companies can appear inexpensive based on P/E ratios while hiding significant risks inside reserves, investment portfolios, or underwriting liabilities.
3. Latest Financial Performance
Warba's audited 2025 financial statements provide an important starting point.
According to the company's audited consolidated financial statements, 2025 insurance revenue was approximately KWD 42.57 million, compared with KWD 42.92 million in 2024.
Net profit attributable to shareholders declined from approximately KWD 5.62 million in 2024 to KWD 4.53 million in 2025.
That represents a decline of roughly 19% in attributable earnings.
The headline numbers therefore tell two different stories:
Revenue was relatively stable.
Profitability weakened substantially.
This is one of the most important issues investors should understand before buying WINSRE.
2024 vs. 2025
| Metric | 2024 | 2025 | Trend |
|---|---|---|---|
| Insurance revenue | KWD 42.92M | KWD 42.57M | Slight decline |
| Net profit | KWD 5.67M | KWD 4.54M | Down |
| Profit attributable to shareholders | KWD 5.62M | KWD 4.53M | Down |
| EPS | ~23.3 fils | ~18.6 fils | Down |
| Investment income | KWD 2.73M | KWD 3.48M | Up |
The combination is important.
Warba did not experience a major collapse in insurance revenue. Instead, profitability was pressured by the cost structure and insurance service performance.
The audited report shows that insurance service result declined from KWD 5.24 million in 2024 to KWD 3.65 million in 2025.
That is a warning sign for investors who want to treat WINSRE primarily as an underwriting business.
4. 2026 Is Showing Some Improvement in Insurance Operations
The latest six-month results provide a more encouraging picture.
For the six months ended June 30, 2026, Warba reported:
Insurance revenue: KWD 23.60 million
Insurance service result: KWD 2.11 million
Net profit attributable to parent shareholders: KWD 2.70 million
EPS: 11.08 fils
The comparable six-month 2025 figures were:
Insurance revenue: KWD 22.23 million
Insurance service result: KWD 1.88 million
Attributable profit: KWD 2.74 million
EPS: 11.24 fils.
This means the first half of 2026 produced a modest improvement in insurance revenue and insurance service result, but total attributable earnings remained slightly below the previous year's level.
H1 2026 vs. H1 2025
| Metric | H1 2025 | H1 2026 | Change |
|---|---|---|---|
| Insurance revenue | KWD 22.23M | KWD 23.60M | +6.1% |
| Insurance service result | KWD 1.88M | KWD 2.11M | +12.0% |
| Attributable net profit | KWD 2.74M | KWD 2.70M | Slight decline |
| EPS | 11.24 fils | 11.08 fils | Slight decline |
This is arguably one of the most important developments for WINSRE investors.
The core insurance business improved, but investment-related profitability did not grow enough to lift total earnings.
5. Investment Income Is an Important Part of the Story
Insurance companies do not make money only from underwriting.
They also invest premiums and shareholder capital.
Warba generated approximately KWD 3.48 million of net investment income in 2025, compared with KWD 2.73 million in 2024.
In the first half of 2026, net investment income was approximately KWD 1.57 million, compared with KWD 2.12 million in the first half of 2025.
That decline is significant.
It suggests that investors should not extrapolate the strong 2025 investment result indefinitely.
For an insurance company, earnings quality is stronger when underwriting generates sustainable profits independently of favorable investment-market conditions.
6. Underwriting Performance Deserves More Attention
One of the strongest reasons to examine Warba carefully is underwriting performance.
The 2025 audited statements show:
Insurance service result before reinsurance contracts held: approximately KWD 18.42 million.
However, after reinsurance-related expenses, the final insurance service result was only approximately KWD 3.65 million.
This illustrates why investors should not look only at gross insurance revenue.
Reinsurance is essential for an insurer because it transfers part of the risk to other insurers. However, reinsurance also carries a cost.
The company's profitability therefore depends on finding the right balance between:
Premium growth + underwriting discipline + claims management + reinsurance cost + investment returns.
This is a critical metric to monitor going forward.
7. Medical Insurance Is an Important Risk Factor
Warba's medical portfolio deserves particular attention.
A December 2025 S&P Global Ratings disclosure indicated that slower-than-expected revenue growth and weaker underwriting performance were mainly driven by the medical portfolio.
The same disclosure stated that Warba had a combined ratio of 85% during the first nine months of 2025, compared with 76% for the referenced earlier period.
For insurance investors, the combined ratio is a critical metric.
Generally:
Below 100% = underwriting profit before investment income
Around 100% = underwriting break-even
Above 100% = underwriting loss
An 85% combined ratio is still profitable from an underwriting perspective, but deterioration in the ratio deserves monitoring.
Medical claims inflation, treatment costs, utilization rates, and pricing discipline can materially affect future profitability.
8. Balance Sheet and Capital Position
Warba's balance sheet is another major strength.
As of June 30, 2026, total group equity was approximately KWD 53.48 million, compared with approximately KWD 54.33 million at the beginning of the year.
The company had approximately:
KWD 53.5 million of total equity
against:
KWD 116.8 million of total assets.
This provides a substantial equity cushion relative to the company's overall asset base.
The balance sheet also needs to be considered in the context of insurance liabilities, which are fundamentally different from ordinary corporate debt.
9. S&P Global Ratings Provides an Important External Check
One of the strongest pieces of external evidence available to investors is Warba's credit rating.
S&P Global Ratings affirmed Warba Insurance and Reinsurance Company's:
BBB+ long-term issuer credit rating
with a:
Positive outlook.
S&P described the company's financial risk profile as strong and its capital and earnings profile as very strong. It also assessed liquidity as excellent.
The positive outlook is particularly interesting.
S&P indicated that the rating could potentially be upgraded if Warba continues to expand profitably while maintaining strong capital adequacy.
This does not mean the stock is automatically attractive.
However, it provides independent evidence that the company has a meaningful financial-strength foundation.
10. The Biggest Risk: Insurance Contract Liabilities
Investors should not treat an insurer's equity balance as equivalent to the equity of a manufacturing or technology company.
Insurance liabilities can be difficult to estimate.
EY, the independent auditor of Warba's 2025 financial statements, identified insurance contract liabilities as a key audit matter.
At December 31, 2025, insurance contract liabilities were approximately KWD 38.19 million.
EY specifically highlighted the judgment involved in estimating incurred claims, future cash flows, claims-cost inflation, medical trends, and actuarial assumptions.
This is normal for an insurance company, but it is still a major investment risk.
A deterioration in claims experience could reduce future profitability and potentially increase required capital.
11. WINSRE Valuation
The valuation is where Warba becomes particularly interesting.
Around early September 2026, WINSRE was trading near KWD 0.177 per share.
At that price, the company had a market capitalization of roughly KWD 43 million.
Market data showed a trailing P/E ratio around 9.6x and a dividend yield around 9%.
This is not an extreme valuation for a profitable insurer.
More importantly, the stock appears to trade below book value.
Using approximately KWD 53.48 million of June 2026 equity and approximately 243.43 million weighted-average shares, estimated book value per share is around:
KWD 0.220 per share
versus a market price around:
KWD 0.177 per share.
That produces an estimated:
Price-to-book ratio ≈ 0.81x
This can be attractive for value investors.
However, a discount to book value is not automatically a bargain.
The market may apply a discount because:
Earnings growth is weak.
The company is small.
Trading liquidity is lower than major global insurers.
The stock is outside the U.S. market.
Insurance reserves are inherently uncertain.
Investment income can fluctuate.
The medical portfolio has shown underwriting pressure.
Therefore, the appropriate question is:
Can Warba generate an adequate return on equity while maintaining capital strength?
12. Dividend Analysis
Dividends are arguably one of WINSRE's strongest attractions.
For fiscal 2025, shareholders approved a cash dividend of:
15 fils per share
or:
15% of nominal share value.
The distribution was approved at the March 25, 2026 annual general meeting, with payment beginning after the relevant entitlement procedures.
The dividend history is notable:
| Fiscal year | Dividend |
|---|---|
| 2021 | ~5.67 fils |
| 2022 | ~7.08 fils |
| 2023 | 8 fils |
| 2024 | 10 fils |
| 2025 | 15 fils |
The longer-term pattern therefore shows substantial dividend growth.
At a share price of KWD 0.177, a 15-fils annual dividend would imply a simple historical yield of approximately:
8.5%
before considering any future changes in price or dividend policy.
This is substantially higher than the dividend yields of many large U.S. insurance companies.
But investors should be careful.
A high dividend yield is not the same thing as a high-quality dividend.
13. Is the Dividend Sustainable?
The 2025 dividend requires careful analysis.
Attributable earnings were approximately KWD 4.53 million.
The approved dividend was approximately KWD 3.65 million.
That suggests a payout ratio of approximately:
80% of attributable earnings.
This is relatively high.
It leaves only a modest portion of annual earnings available for retained capital.
For a growing insurance company, retained earnings are important because capital supports underwriting capacity and regulatory solvency.
The dividend is therefore attractive, but investors should not assume that the 15-fils payout will rise every year.
A more conservative assumption would be:
Future dividend growth depends on earnings growth and capital requirements.
14. Stock Price Momentum
WINSRE has also experienced significant price movement during 2026.
Historical market data shows the stock moving from the mid-KWD 0.16 range during parts of the summer toward approximately KWD 0.18 by early September.
The 52-week range was approximately:
KWD 0.159 – KWD 0.213
according to market data available in early September 2026.
This tells investors two things.
First, the stock can move meaningfully despite its small market capitalization.
Second, investors should avoid assuming that a stock trading below book value cannot decline further.
Small-cap foreign equities can remain undervalued for long periods.
15. Free Float and Liquidity
Boursa Kuwait data indicates that WINSRE has a free float of approximately 36.25%.
For a U.S. investor, this matters.
A company can have an attractive P/E and P/B ratio but still be difficult to trade efficiently if liquidity is limited.
Investors should therefore consider:
Average daily trading volume
Bid/ask spreads
Brokerage access
Currency conversion
Settlement procedures
Position size
This makes WINSRE more appropriate for a small portfolio allocation than for a large institutional-style position.
16. Investment Strengths
1. Attractive valuation
A sub-1x price-to-book valuation provides a potential margin of safety if book value remains economically sound.
2. Strong dividend history
The 2025 distribution of 15 fils is attractive relative to the share price.
3. Positive S&P outlook
BBB+ with a positive outlook provides a stronger credit-quality signal than an un-rated microcap insurer.
4. Improving insurance service result
The first half of 2026 showed insurance service result growth of approximately 12% year over year.
5. Strong capital base
Shareholders' equity remained above KWD 53 million at June 2026.
6. International diversification
For a U.S. investor, WINSRE provides exposure to the Kuwaiti insurance market rather than another U.S. financial company.
17. Investment Risks
1. Earnings decline
2025 attributable earnings declined approximately 19% year over year.
2. Medical underwriting pressure
S&P highlighted weaker underwriting performance associated with the medical portfolio.
3. High payout ratio
A dividend of 15 fils against approximately 18.6 fils of 2025 EPS implies a high payout ratio.
4. Investment-income sensitivity
Investment income declined during the first half of 2026.
5. Small-cap liquidity
WINSRE is considerably smaller and less liquid than major international insurers.
6. Foreign exchange risk
U.S. investors face KWD/USD currency exposure.
7. Foreign-market access
Not every U.S. brokerage provides convenient access to Kuwait-listed securities.
8. Insurance reserve risk
Claims estimates depend on actuarial assumptions and future medical and claims-cost trends.
18. WINSRE Compared With a Typical U.S. Insurance Stock
For an American investor, the easiest way to understand Warba is to compare its investment characteristics with the large U.S. insurance sector.
| Factor | WINSRE | Large U.S. Insurer |
|---|---|---|
| Market | Kuwait | United States |
| Market capitalization | Small | Usually much larger |
| Liquidity | Lower | Generally higher |
| P/B valuation | Potentially below 1x | Often higher |
| Dividend yield | High | Usually lower |
| International exposure | High for U.S. investor | Low |
| Currency risk | KWD/USD | Primarily USD |
| Analyst coverage | Limited | Extensive |
| Capital transparency | Strong regulatory disclosures | Strong |
| Growth potential | Moderate | Varies |
| Risk profile | Higher | Varies |
This comparison explains why WINSRE can look cheap.
Investors are not comparing identical businesses.
They are comparing different markets, currencies, liquidity profiles, regulatory environments, and investor bases.
19. What Could Drive WINSRE Higher?
Several catalysts could improve the investment case.
Improving underwriting
If Warba can improve its combined ratio and medical portfolio profitability, earnings could recover.
Higher insurance revenue
Growth of 3–5% annually would gradually increase the company's earnings capacity if margins are maintained.
Stable investment income
A stable investment portfolio could support earnings while underwriting improves.
Credit-rating upgrade
A future upgrade from BBB+ could improve institutional perception of the company.
Narrowing of the P/B discount
If investors become more confident in the company's capital quality, WINSRE could eventually trade closer to book value.
20. What Could Push the Stock Lower?
The opposite scenario is also possible.
The biggest downside risks include:
Higher claims inflation
Higher medical or accident claims could reduce underwriting profitability.
Weak investment markets
Investment income can fall if portfolio returns decline.
Dividend reduction
A lower dividend could remove one of the major attractions of the stock.
Capital requirements
Insurance regulation can require companies to retain capital instead of distributing it.
Foreign investor discount
International investors may continue to demand a valuation discount because of market accessibility and liquidity.
21. A Simple Valuation Scenario
Using the June 2026 book value estimate of approximately KWD 0.220 per share, consider three valuation scenarios.
Bear case
P/B = 0.70x
Estimated value:
KWD 0.154
Base case
P/B = 0.90x
Estimated value:
KWD 0.198
Bull case
P/B = 1.10x
Estimated value:
KWD 0.242
These are scenario calculations, not analyst price targets.
The exercise demonstrates why book value is important for an insurer.
At approximately KWD 0.177, the market price is already below estimated book value.
But investors need evidence that book value can continue to compound.
22. What American Value Investors Should Watch
A U.S. investor considering WINSRE should monitor five numbers every quarter.
1. Insurance revenue
Is the company growing organically?
2. Insurance service result
Is underwriting actually generating more profit?
3. Combined ratio
Is claims and expense discipline improving?
4. Investment income
How dependent are earnings on financial-market performance?
5. Shareholders' equity
Is book value increasing after dividends?
These five indicators provide a better picture than EPS alone.
23. The Most Important 2026 Question
The central investment question for Warba is no longer simply:
"Is Warba profitable?"
The answer is clearly yes.
The more important question is:
"Can Warba grow its insurance franchise while maintaining strong capital adequacy and sustainable dividend distributions?"
If the answer is yes, a sub-1x P/B valuation could become increasingly interesting.
If earnings continue declining while dividends consume most of the available profits, the apparent valuation discount could remain justified.
24. Final Investment Assessment
Warba Insurance and Reinsurance Company is an unusual stock for an American investor.
It is small.
It is foreign.
It has limited analyst coverage.
It has relatively low liquidity compared with major U.S. insurers.
But those disadvantages are precisely why the valuation can be interesting.
The company combines:
A profitable insurance operation
More than five decades of operating history
A strong capital position
BBB+ credit ratings with a positive outlook
A potentially attractive price-to-book ratio
A significant dividend
Improving first-half 2026 insurance service performance
At the same time, investors must recognize that 2025 earnings declined, medical underwriting remains an area to monitor, and the dividend payout ratio is relatively high.
WorldReview1989 Investment Scorecard
| Category | Assessment |
|---|---|
| Business stability | ★★★★☆ |
| Balance sheet | ★★★★☆ |
| Capital strength | ★★★★☆ |
| Valuation | ★★★★☆ |
| Dividend appeal | ★★★★★ |
| Earnings growth | ★★★☆☆ |
| Underwriting quality | ★★★☆☆ |
| Liquidity | ★★☆☆☆ |
| International investor accessibility | ★★☆☆☆ |
| Overall risk | Medium–High |
Bottom Line
WINSRE looks more interesting as a value-and-income stock than as a high-growth insurance stock.
The combination of a sub-book valuation, substantial dividend distribution, strong capital position, and BBB+ positive credit outlook creates a credible investment case.
However, the decline in 2025 earnings and the pressure visible in parts of the underwriting business prevent this from being a straightforward "buy and forget" investment.
For U.S. investors, Warba is best viewed as a small international insurance position for investors comfortable with Kuwait-market, currency, liquidity, and insurance-specific risks.
The most attractive scenario would be one in which insurance revenue continues growing, the combined ratio improves, investment income stabilizes, book value compounds, and the company maintains its strong capital position.
If those conditions develop, the current discount to book value could become increasingly difficult for the market to justify.
Primary Sources and References
Warba Insurance & Reinsurance Company – Financial Reports
The company publishes its annual and interim financial statements, including the audited 2025 financial statements and 2026 interim reports. Warba Insurance Financial Reports
Warba Insurance – Company Disclosures
Official corporate disclosures, board announcements, financial announcements, treasury-share information, and regulatory disclosures. Warba Insurance Company Disclosures
Boursa Kuwait
Official Kuwait Stock Exchange information and listed-company/free-float data for WINSRE. Boursa Kuwait
Warba Insurance – 2025 Audited Financial Statements
The 2025 statements were audited by EY and prepared under IFRS Accounting Standards.
Warba Insurance – H1 2026 Financial Statements
The June 30, 2026 interim financial statements provide the latest six-month financial information used in this analysis.
S&P Global Ratings
Warba's BBB+ financial strength/issuer rating and positive outlook provide an independent credit-quality reference.
Kuwait Capital Markets Authority
The CMA provides the regulatory framework governing Kuwait's capital markets and securities activities. Kuwait Capital Markets Authority
About the Author
David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Personal Finance
- Investing & Stock Market
- Cryptocurrency & Blockchain
- Insurance
- Banking
- Real Estate
- Business & Entrepreneurship
- Digital Marketing
- Financial Technology (FinTech)
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks
Join Facebook Group